# BRD2

## Overview
BRD2 is a gene that encodes the protein bromodomain-containing 2, a member of the bromodomain and extra-terminal (BET) protein family. This protein is characterized by the presence of two tandem bromodomains and an extra-terminal domain, which are crucial for its role in recognizing acetylated lysine residues on histones and facilitating protein-protein interactions, respectively (Huang2007Solution; Denis2006Identification). As a nuclear protein, bromodomain-containing 2 functions primarily as a transcriptional regulator, influencing gene expression and cell cycle progression by acting as a scaffold for transcriptional machinery and chromatin remodeling complexes (Hnilicová2013The; Fujisawa2017Functions). The gene's involvement in transcriptional regulation and chromatin dynamics underscores its significance in cellular processes and its association with various diseases, including neurological disorders such as juvenile myoclonic epilepsy (Pal2003BRD2; Velíšek2011GABAergic).

## Structure
BRD2 is a member of the BET protein family, characterized by the presence of two tandem bromodomains (BD1 and BD2) at the N-terminus and an extra-terminal (ET) domain at the C-terminus (Huang2007Solution; Denis2006Identification). The bromodomains are highly conserved, consisting of a four-helix, left-twisted bundle with a hydrophobic cleft between two conserved loops, which allows them to bind acetylated lysine residues on histones, particularly acetylated lysine 12 of histone H4 (Umehara2010Structural; Denis2006Identification). The second bromodomain (BD2) of BRD2 features a unique π-helix in the ZA loop, contributing to its specific interaction with acetylated histone tails (Huang2007Solution).

The ET domain is a protein-protein interaction motif that recruits additional co-activators and is crucial for BRD2's function in transcriptional regulation (Werner2020Comparative). BRD2 also contains a coiled-coil (CC) domain, which, along with the ET domain, is important for mediating interactions with transcriptional complexes (Werner2020Comparative).

BRD2 undergoes post-translational modifications, such as acetylation, which are essential for its role in transcriptional activation and chromatin remodeling (Denis2006Identification). The gene is regulated at multiple levels, including transcription, splicing, and translation, with alternative splicing leading to different isoforms (Shang2011The).

## Function
BRD2 is a member of the BET protein family, which includes BRD3, BRD4, and BRDT. It plays a critical role in regulating gene expression and cell cycle progression in healthy human cells. BRD2 contains two N-terminal bromodomains that recognize acetylated histones and a C-terminal domain that facilitates protein-protein interactions. This structure allows BRD2 to bind to acetylated chromatin and recruit components of the transcriptional machinery, influencing chromatin structure and transcriptional activation (Hnilicová2013The; Fujisawa2017Functions).

BRD2 functions as a scaffold in transcriptional regulation, particularly in the activation of cyclin A during the S-phase of the cell cycle. It recruits E2F transcription factors and chromatin-remodeling activities to the cyclin A promoter, facilitating transcriptional activation necessary for cell cycle progression (SINHA2005Bromodomain; Denis2006Identification). BRD2 is also involved in chromatin remodeling, interacting with complexes such as Swi/Snf, and plays a role in histone modification, although it does not possess intrinsic histone acetyltransferase activity (SINHA2005Bromodomain; Denis2006Identification).

In addition to its role in transcription, BRD2 influences alternative splicing and is associated with the regulation of genes linked to cancer development. It is primarily active in the nucleus, where it interacts with chromatin and affects both transcription and splicing processes (Hnilicová2013The).

## Clinical Significance
The BRD2 gene is implicated in several neurological disorders, most notably juvenile myoclonic epilepsy (JME), a common form of idiopathic generalized epilepsy. Studies have identified BRD2 as a major susceptibility gene for JME, with significant linkage disequilibrium observed between JME and specific haplotypes in the BRD2 gene region (Pal2003BRD2). BRD2 haploinsufficiency in mice has been shown to lead to increased seizure susceptibility and spontaneous seizures, suggesting a role in epilepsy-related EEG traits (Velíšek2011GABAergic). This is thought to be due to a deficit in GABAergic neurons, particularly in the basal ganglia, which is crucial for controlling seizures (Velíšek2011GABAergic).

Alterations in BRD2 expression, particularly through DNA methylation of its promoter region, have been associated with JME in Caucasian populations. This epigenetic modification may lead to reduced BRD2 expression, contributing to seizure susceptibility (Pathak2018DNA). The gene's proximity to the TAP1 gene has also led to speculation about potential interactions affecting its expression (Velíšek2011GABAergic). Additionally, BRD2 polymorphisms have been linked to photoparoxysmal response, a condition related to photosensitive epilepsies, indicating its broader role in epilepsy-related conditions (Lorenz2006Association).

## Interactions
BRD2 interacts with acetylated histones, particularly through its bromodomains, which bind to acetylated lysines on histones such as H4. This interaction is crucial for BRD2's role in transcriptional regulation and chromatin remodeling (Draker2012A; Huang2007Solution). BRD2 is part of a multiprotein complex that includes E2F proteins, histone acetyltransferases (HATs), and components of the SWI/SNF chromatin remodeling complex, such as Baf155 and Brg-1. These interactions suggest that BRD2 acts as a scaffold for recruiting transcriptional control proteins and chromatin remodeling factors to specific promoters, such as the cyclin A promoter (Denis2006Identification).

BRD2 also forms complexes with other proteins, including BRD7, where the interaction is mediated by the C-terminal region of BRD2. This interaction predominantly occurs in the nucleus, indicating a role in nuclear processes (Zhou2006BRD2). The protein's bromodomains are essential for its function, as they facilitate the recognition of acetylated histone tails, which is critical for transcriptional activation (LeRoy2008The). BRD2's interactions with chromatin and transcription machinery underscore its role in regulating gene expression and cell cycle progression (Denis2006Identification).


## References


[1. (Werner2020Comparative) Michael T. Werner, Hongxin Wang, Nicole Hamagami, Sarah C. Hsu, Jennifer A. Yano, Aaron J. Stonestrom, Vivek Behera, Yichen Zong, Joel P. Mackay, and Gerd A. Blobel. Comparative structure-function analysis of bromodomain and extraterminal motif (bet) proteins in a gene-complementation system. Journal of Biological Chemistry, 295(7):1898–1914, February 2020. URL: http://dx.doi.org/10.1074/jbc.ra119.010679, doi:10.1074/jbc.ra119.010679. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.010679)

[2. (SINHA2005Bromodomain) Anupama SINHA, Douglas V. FALLER, and Gerald V. DENIS. Bromodomain analysis of brd2-dependent transcriptional activation of cyclin a. Biochemical Journal, 387(1):257–269, March 2005. URL: http://dx.doi.org/10.1042/bj20041793, doi:10.1042/bj20041793. This article has 143 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20041793)

[3. (Zhou2006BRD2) Ming Zhou, Xiao-Jie Xu, Hou-De Zhou, Hua-Ying Liu, Jia-Jin He, Xiao-Ling Li, Cong Peng, Wei Xiong, Song-Qing Fan, Jian-Hong Lu, Jue Ouyang, Shou-Rong Shen, Bo Xiang, and Gui-Yuan Li. Brd2 is one of brd7-interacting proteins and its over-expression could initiate apoptosis. Molecular and Cellular Biochemistry, 292(1–2):205–212, June 2006. URL: http://dx.doi.org/10.1007/s11010-006-9233-4, doi:10.1007/s11010-006-9233-4. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-006-9233-4)

[4. (Pathak2018DNA) Shilpa Pathak, James Miller, Emily C. Morris, William C. L. Stewart, and David A. Greenberg. <scp>dna</scp> methylation of the <scp>brd</scp>2 promoter is associated with juvenile myoclonic epilepsy in caucasians. Epilepsia, 59(5):1011–1019, April 2018. URL: http://dx.doi.org/10.1111/epi.14058, doi:10.1111/epi.14058. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/epi.14058)

[5. (Huang2007Solution) Hongda Huang, Jiahai Zhang, Weiqun Shen, Xingsheng Wang, Jiawen Wu, Jihui Wu, and Yunyu Shi. Solution structure of the second bromodomain of brd2 and its specific interaction with acetylated histone tails. BMC Structural Biology, September 2007. URL: http://dx.doi.org/10.1186/1472-6807-7-57, doi:10.1186/1472-6807-7-57. This article has 45 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1472-6807-7-57)

[6. (Pal2003BRD2) Deb K. Pal, Oleg V. Evgrafov, Paula Tabares, Fengli Zhang, Martina Durner, and David A. Greenberg. Brd2 (ring3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy. The American Journal of Human Genetics, 73(2):261–270, August 2003. URL: http://dx.doi.org/10.1086/377006, doi:10.1086/377006. This article has 146 citations.](https://doi.org/10.1086/377006)

[7. (Lorenz2006Association) Susanne Lorenz, Kirsten P. Taylor, Anne Gehrmann, Tim Becker, Hiltrud Muhle, Meike Gresch, Ulrike Tauer, Thomas Sander, and Ulrich Stephani. Association of brd2 polymorphisms with photoparoxysmal response. Neuroscience Letters, 400(1–2):135–139, May 2006. URL: http://dx.doi.org/10.1016/j.neulet.2006.02.026, doi:10.1016/j.neulet.2006.02.026. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neulet.2006.02.026)

[8. (Draker2012A) Ryan Draker, Marlee K. Ng, Elizabeth Sarcinella, Vladimir Ignatchenko, Thomas Kislinger, and Peter Cheung. A combination of h2a.z and h4 acetylation recruits brd2 to chromatin during transcriptional activation. PLoS Genetics, 8(11):e1003047, November 2012. URL: http://dx.doi.org/10.1371/journal.pgen.1003047, doi:10.1371/journal.pgen.1003047. This article has 87 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1003047)

[9. (Hnilicová2013The) Jarmila Hnilicová, Samira Hozeifi, Eva Stejskalová, Eva Dušková, Ina Poser, Jana Humpolíčková, Martin Hof, and David Staněk. The c-terminal domain of brd2 is important for chromatin interaction and regulation of transcription and alternative splicing. Molecular Biology of the Cell, 24(22):3557–3568, November 2013. URL: http://dx.doi.org/10.1091/mbc.e13-06-0303, doi:10.1091/mbc.e13-06-0303. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e13-06-0303)

[10. (LeRoy2008The) Gary LeRoy, Brenden Rickards, and S.J. Flint. The double bromodomain proteins brd2 and brd3 couple histone acetylation to transcription. Molecular Cell, 30(1):51–60, April 2008. URL: http://dx.doi.org/10.1016/j.molcel.2008.01.018, doi:10.1016/j.molcel.2008.01.018. This article has 303 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2008.01.018)

[11. (Umehara2010Structural) Takashi Umehara, Yoshihiro Nakamura, Moon Kyoo Jang, Kazumi Nakano, Akiko Tanaka, Keiko Ozato, Balasundaram Padmanabhan, and Shigeyuki Yokoyama. Structural basis for acetylated histone h4 recognition by the human brd2 bromodomain. Journal of Biological Chemistry, 285(10):7610–7618, March 2010. URL: http://dx.doi.org/10.1074/jbc.M109.062422, doi:10.1074/jbc.m109.062422. This article has 145 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M109.062422)

[12. (Shang2011The) Enyuan Shang, Qingping Cui, Xiangyuan Wang, Cheryl Beseler, David A. Greenberg, and Debra J. Wolgemuth. The bromodomain-containing gene brd2 is regulated at transcription, splicing, and translation levels. Journal of Cellular Biochemistry, 112(10):2784–2793, September 2011. URL: http://dx.doi.org/10.1002/jcb.23192, doi:10.1002/jcb.23192. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.23192)

[13. (Denis2006Identification) Gerald V. Denis, Mark E. McComb, Douglas V. Faller, Anupama Sinha, Paul B. Romesser, and Catherine E. Costello. Identification of transcription complexes that contain the double bromodomain protein brd2 and chromatin remodeling machines. Journal of Proteome Research, 5(3):502–511, February 2006. URL: http://dx.doi.org/10.1021/pr050430u, doi:10.1021/pr050430u. This article has 184 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/pr050430u)

[14. (Velíšek2011GABAergic) Libor Velíšek, Enyuan Shang, Jana Velíšková, Tamar Chachua, Stephania Macchiarulo, Giorgi Maglakelidze, Debra J. Wolgemuth, and David A. Greenberg. Gabaergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of brd2 haploinsufficiency in juvenile myoclonic epilepsy. PLoS ONE, 6(8):e23656, August 2011. URL: http://dx.doi.org/10.1371/journal.pone.0023656, doi:10.1371/journal.pone.0023656. This article has 67 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0023656)

[15. (Fujisawa2017Functions) Takao Fujisawa and Panagis Filippakopoulos. Functions of bromodomain-containing proteins and their roles in homeostasis and cancer. Nature Reviews Molecular Cell Biology, 18(4):246–262, January 2017. URL: http://dx.doi.org/10.1038/nrm.2016.143, doi:10.1038/nrm.2016.143. This article has 446 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm.2016.143)